Showing results (31-40 of 180) with videos related to

Sort By:
Pageof 18
Health Affairs (Project Hope)|May 8, 2018
Strategies For Clinical Implementation: Precision Oncology At Three Distinct InstitutionsLincoln D Nadauld, James M Ford, Daryl Pritchard, et al.
Cancer Research|April 9, 2009
Defective repair of oxidative dna damage in triple-negative breast cancer confers sensitivity to inhibition of poly(ADP-ribose) polymeraseElizabeth Alli, Vandana B Sharma, Preethi Sunderesakumar, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 14, 2013
A young woman with bilateral breast cancer: identifying a genetic cause and implications for managementMonique A de Bruin, James M Ford, Allison W Kurian
Cancer Genetics|March 14, 2022
Somatic tumor testing implications for Lynch syndrome germline genetic testingKathleen Barrus, Natasha Purington, Nicolette Chun, et al.
JNCI Cancer Spectrum|April 8, 2020
Germline Testing for Patients With BRCA1/2 Mutations on Somatic Tumor TestingKatherine Vlessis, Natasha Purington, Nicolette Chun, et al.
Molecular Pharmacology|February 3, 2007
Reversal of stathmin-mediated resistance to paclitaxel and vinblastine in human breast carcinoma cellsElizabeth Alli, Jin-Ming Yang, James M Ford, et al.
Cancer Research|September 14, 2014
Therapeutic targeting of BRCA1-mutated breast cancers with agents that activate DNA repairElizabeth Alli, David Solow-Cordero, Stephanie C Casey, et al.
Journal of the American Chemical Society|July 15, 2016
A Chimeric ATP-Linked Nucleotide Enables Luminescence Signaling of Damage Surveillance by MTH1, a Cancer TargetDebin Ji, Andrew A Beharry, James M Ford, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 10, 2010
Longer relative telomere length in blood from women with sporadic and familial breast cancer compared with healthy controlsMaria M Gramatges, Melinda L Telli, Raymond Balise, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 19, 2011
A two-antibody mismatch repair protein immunohistochemistry screening approach for colorectal carcinomas, skin sebaceous tumors, and gynecologic tract carcinomasAmirkaveh Mojtahed, Iris Schrijver, James M Ford, et al.
Pageof 18